Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IDEAYA Biosciences, Inc. | SVP, General Counsel | Stock Option (Right to Buy) | 140K | Sep 26, 2024 | Direct | ||
GW PHARMACEUTICALS PLC | Chief Legal Officer | Ordinary Shares | 0 | May 5, 2021 | Direct | ||
GW PHARMACEUTICALS PLC | Chief Legal Officer | Share Options | 0 | May 5, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IDYA | IDEAYA Biosciences, Inc. | Sep 26, 2024 | 1 | $0 | 4 | Sep 27, 2024 | SVP, General Counsel |
IDYA | IDEAYA Biosciences, Inc. | Sep 18, 2024 | 0 | $0 | 3 | Sep 27, 2024 | SVP, General Counsel |
GWPH | GW PHARMACEUTICALS PLC | May 5, 2021 | 12 | $0 | 4 | May 7, 2021 | Chief Legal Officer |